Cargando…
Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association’s COVID-19 Cardiovascular Disease Registry
BACKGROUND: Statins have anti-inflammatory and immunomodulatory effects that may reduce the severity of coronavirus disease 2019 (COVID-19), in which organ dysfunction is mediated by severe inflammation. Large studies with diverse populations evaluating statin use and outcomes in COVID-19 are lackin...
Autores principales: | Daniels, Lori B., Ren, Junting, Kumar, Kris, Bui, Quan M., Zhang, Jing, Zhang, Xinlian, Sawan, Mariem A., Eisen, Howard, Longhurst, Christopher A., Messer, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281996/ https://www.ncbi.nlm.nih.gov/pubmed/34264974 http://dx.doi.org/10.1371/journal.pone.0254635 |
Ejemplares similares
-
Relation of Statin Use Prior to Admission to Severity and Recovery Among COVID-19 Inpatients
por: Daniels, Lori B., et al.
Publicado: (2020) -
Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry
por: Torres-Peña, José David, et al.
Publicado: (2021) -
Comment on: “Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry”
por: Vuorio, Alpo, et al.
Publicado: (2021) -
Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry
por: Bhatt, Ankeet S., et al.
Publicado: (2023) -
Prior Statin vs In-Hospital Statin Usage in Severe COVID-19: Review and Meta-Analysis
por: Alhallak, Iad, et al.
Publicado: (2023)